Industry news that matters to you.  Learn more

Archives for May 2012

Courtagen Submits Pre-IDE Information Package for the Avantra Q400 Workstation and QPDx BioChip

Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that the company has submitted its first pre- IDE (Investigational Device Exemption) information package to the U.S. Food and Drug Administration for the Company’s Avantra® Q400 BioMarker Workstation and QPDX® BioChip for the measurement of C-reactive protein (CRP). Courtagen is also pursuing a CE Mark Approval for the European Union.

OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel

OPKO Health, Inc. (NYSE:OPK) today announced execution of a license agreement granting International Health Technology, Ltd. (Cambridge, England) the right to offer OPKO’s novel panel of kallikrein biomarkers and associated algorithm for the detection of prostate cancer in a laboratory setting in the U.K., Ireland, Sweden and Denmark. The OPKO panel represents the culmination of a decade of research by scientists in Europe and the U.S. and has been demonstrated in over 10,000 patients to predict the probability of cancer-positive biopsy in men suspect for prostate cancer. Studies have shown use of the panel could eliminate a significant amount of unnecessary prostate biopsies, demonstrating a reduction of over 50%.

Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing

Genomic Health, Inc. (Nasdaq: GHDX) and OncoMed Pharmaceuticals, Inc. (OncoMed) today announced a strategic alliance to use Next Generation Sequencing (NGS) to identify biomarkers that can be applied to the clinical development of OncoMed’s novel antibody cancer therapeutics.

Videos: Recent Advances in Biomarkers of Parkinson’s Disease

Presentations from the Covance Symposium Recent Advances in Biomarkers of Parkinson’s Disease at the 2011 Society for Neuroscience Conference is now available to watch on the Covance website. Listen to discussions regarding recent innovations in imaging, genomic, proteomic, and fluid biomarkers of Parkinson’s disease and their potential application to the clinic.

AssureRx Health Launches Personalized Medicine Test for ADHD

AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.